Current treatment status and medical cost for multiple sclerosis based on analysis of a Japanese claims database.

These results provide up-to-date information on the demographics, medical treatment and cost status of MS in almost real-time by using a claims database. They suggest that claims data analysis can effectively support medical policymaking.